Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 130 (3), 338-347
- https://doi.org/10.1016/j.pharmthera.2011.02.003
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Mapping Spatial Relationships between Residues in the Ligand-Binding Domain of the 5-Ht3 Receptor Using a Molecular RulerBiophysical Journal, 2010
- Serotonin 3A Receptor Subtype as an Early and Protracted Marker of Cortical Interneuron SubpopulationsCerebral Cortex, 2010
- The 5-HT3 receptor – the relationship between structure and functionNeuropharmacology, 2009
- Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A ReceptorPublished by Elsevier BV ,2008
- A Hydrogen Bond in Loop A Is Critical for the Binding and Function of the 5-HT3 ReceptorBiochemistry, 2008
- Modular Design of Cys-loop Ligand-gated Ion Channels: Functional 5-HT3 and GABA ρ1 Receptors Lacking the Large Cytoplasmic M3M4 LoopThe Journal of general physiology, 2008
- Inhibition of human 5-HT3A and 5-HT3AB receptors by etomidate, propofol and pentobarbitalEuropean Journal of Pharmacology, 2007
- Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channelNature, 2004
- Alcohols potentiate the function of 5‐HT3 receptor‐channels on NCB‐20 neuroblastoma cells by favouring and stabilizing the open channel stateThe Journal of Physiology, 1998
- 5-HT3 Receptor AntagonistsDrugs, 1991